Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue

Go back to Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue
(NASDAQ: TSHA) Delayed: 5.02 -0.14 (2.71%)
Previous Close $5.16    52 Week High
Open $5.16    52 Week Low
Day High $5.28    P/E N/A 
Day Low $4.96    EPS
Volume 4,340,751